ondansetron has been researched along with Abnormalities, Congenital in 8 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the association between ondansetron exposure during pregnancy and the risks of spontaneous abortion, stillbirth, and major congenital malformations." | 9.12 | Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort. ( Dahl, M; Dormuth, CR; Filion, KB; Fisher, A; Lu, X; Ma, Z; Moriello, C; Paterson, JM; Platt, RW; Raymond, CB; Reynier, P; Suissa, S; Winquist, B; Wu, F; Zhang, J, 2021) |
| "Ondansetron, not approved for use in pregnancy, is increasingly being prescribed for nausea and vomiting in pregnancy and hyperemesis gravidarum." | 8.98 | Ondansetron in Pregnancy and the Risk of Congenital Malformations: A Systematic Review. ( Campbell, S; Chari, R; Lavecchia, M; Ross, S, 2018) |
| "This is an analysis of fetal outcome in pregnancies exposed to ondansetron to treat Hyperemesis Gravidarum (HG)." | 7.83 | Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States. ( Fejzo, MS; MacGibbon, KW; Mullin, PM, 2016) |
| "Our study did not detect any adverse outcomes from the use of ondansetron in pregnancy but could not conclude that ondansetron is safe to use in pregnancy." | 7.79 | Off-label use of ondansetron in pregnancy in Western Australia. ( Bower, C; Colvin, L; Gill, AW; Slack-Smith, L; Stanley, FJ, 2013) |
| "To study the association between ondansetron exposure during pregnancy and the risks of spontaneous abortion, stillbirth, and major congenital malformations." | 5.12 | Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort. ( Dahl, M; Dormuth, CR; Filion, KB; Fisher, A; Lu, X; Ma, Z; Moriello, C; Paterson, JM; Platt, RW; Raymond, CB; Reynier, P; Suissa, S; Winquist, B; Wu, F; Zhang, J, 2021) |
| "Ondansetron, not approved for use in pregnancy, is increasingly being prescribed for nausea and vomiting in pregnancy and hyperemesis gravidarum." | 4.98 | Ondansetron in Pregnancy and the Risk of Congenital Malformations: A Systematic Review. ( Campbell, S; Chari, R; Lavecchia, M; Ross, S, 2018) |
| "This is an analysis of fetal outcome in pregnancies exposed to ondansetron to treat Hyperemesis Gravidarum (HG)." | 3.83 | Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States. ( Fejzo, MS; MacGibbon, KW; Mullin, PM, 2016) |
| "Our study did not detect any adverse outcomes from the use of ondansetron in pregnancy but could not conclude that ondansetron is safe to use in pregnancy." | 3.79 | Off-label use of ondansetron in pregnancy in Western Australia. ( Bower, C; Colvin, L; Gill, AW; Slack-Smith, L; Stanley, FJ, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Kirby, RS | 2 |
| Damkier, P | 1 |
| Kaplan, YC | 1 |
| Shechtman, S | 1 |
| Diav-Citrin, O | 1 |
| Cassina, M | 1 |
| Weber-Schoendorfer, C | 1 |
| Cleary, B | 1 |
| Hodson, K | 1 |
| Dormuth, CR | 1 |
| Winquist, B | 1 |
| Fisher, A | 1 |
| Wu, F | 1 |
| Reynier, P | 1 |
| Suissa, S | 1 |
| Dahl, M | 1 |
| Ma, Z | 1 |
| Lu, X | 1 |
| Zhang, J | 1 |
| Raymond, CB | 1 |
| Filion, KB | 1 |
| Platt, RW | 1 |
| Moriello, C | 1 |
| Paterson, JM | 1 |
| Lavecchia, M | 1 |
| Chari, R | 1 |
| Campbell, S | 1 |
| Ross, S | 1 |
| Zambelli-Weiner, A | 1 |
| Via, C | 1 |
| Yuen, M | 1 |
| Weiner, DJ | 1 |
| Kiernan, E | 1 |
| Jones, KL | 1 |
| Colvin, L | 1 |
| Gill, AW | 1 |
| Slack-Smith, L | 1 |
| Stanley, FJ | 1 |
| Bower, C | 1 |
| Fejzo, MS | 1 |
| MacGibbon, KW | 1 |
| Mullin, PM | 1 |
3 reviews available for ondansetron and Abnormalities, Congenital
| Article | Year |
|---|---|
Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort.
Topics: Abortion, Spontaneous; Adult; Antiemetics; Canada; Cohort Studies; Congenital Abnormalities; Databas | 2021 |
Ondansetron in Pregnancy and the Risk of Congenital Malformations: A Systematic Review.
Topics: Antiemetics; Congenital Abnormalities; Female; Humans; Hyperemesis Gravidarum; Ondansetron; Pregnanc | 2018 |
Medications that Cause Fetal Anomalies and Possible Prevention Strategies.
Topics: Abnormalities, Drug-Induced; Acetaminophen; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Analg | 2019 |
5 other studies available for ondansetron and Abnormalities, Congenital
| Article | Year |
|---|---|
Ondansetron should never be used in pregnancy.
Topics: Antiemetics; Congenital Abnormalities; Female; Humans; Hyperemesis Gravidarum; Ondansetron; Pregnanc | 2021 |
Ondansetron should never be used in pregnancy: Against: Ondansetron in pregnancy revisited.
Topics: Antiemetics; Congenital Abnormalities; Female; Humans; Hyperemesis Gravidarum; Ondansetron; Pregnanc | 2021 |
First trimester ondansetron exposure and risk of structural birth defects.
Topics: Adult; Antiemetics; Congenital Abnormalities; Female; Humans; Male; Maternal-Fetal Exchange; Odds Ra | 2019 |
Off-label use of ondansetron in pregnancy in Western Australia.
Topics: Adult; Antiemetics; Congenital Abnormalities; Female; Humans; Hyperemesis Gravidarum; Infant, Newbor | 2013 |
Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States.
Topics: Abortion, Spontaneous; Adolescent; Adult; Antiemetics; Child; Congenital Abnormalities; Female; Huma | 2016 |